Humic acid induces expression of tissue factor by cultured endothelial cells: regulation by cytosolic calcium and protein kinase C.
Blackfoot disease is a thrombotic peripheral vascular disease causally related to the fluorescent humic acid (HA) found in the drinking water of wells in endemic areas in Taiwan. In this study we examined the effect of HA on tissue factor (TF) expression by vascular endothelial cells. Incubation of cultured human umbilical vein endothelial cells (HUVEC) with HA isolated from endemic area drinking water or with a synthetic humic acid polymer (SHA), resulted in enhanced cell surface expression of TF activity by HUVEC. The intracellular calcium level ([Ca2+]i) was measured using a calcium-specific fluorescent probe, fura 2. Changes in [Ca2+]i level were followed and quantitatively analyzed by spectrofluorometric microscopy, after incubation of the fura 2-loaded HUVEC with HA or SHA in a medium containing 1.8 mM CaCl2. Both HA and SHA increased [Ca2+]i in the presence of extracellular calcium ions, but not in their absence, indicating that influx of extracellular Ca2+ occurred during incubation of HUVEC with HA or SHA. Verapamil, a potent calcium channel blocker, did not abolish the enhancement of [Ca2+]i induced by HA or SHA, indicating that specific calcium channels may not be involved in the HA/SHA-induced elevation of [Ca2+]i. The elevated [Ca2+]i level induced by HA or SHA returned to basal level following removal of HA or SHA and incubation of the washed cells in medium containing 1.8 mM CaCl2. All these changes occurred in the absence of significant cytotoxic effects.(ABSTRACT TRUNCATED AT 250 WORDS)
Institute of Biomedical Sciences, Academia Sinico, Taipei, Taiwan, R.O.C.
H L
HL
Yang
F J
FJ
Lu
S L
SL
Wung
H C
HC
Chiu
D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D002118:Calcium / Q000502:physiology*; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D006812:Humic Substances / Q000009:adverse effects / Q000494:pharmacology*; D007424:Intracellular Fluid / Q000378:metabolism; D007546:Isoquinolines / Q000494:pharmacology; D016491:Peripheral Vascular Diseases / Q000139:chemically induced; D010879:Piperazines / Q000494:pharmacology; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000502:physiology*; D013624:Taiwan; D013925:Thromboplastin / Q000096:biosynthesis*; D014471:Umbilical Veins; D014700:Verapamil / Q000494:pharmacology; D014881:Water Supply
D006812:Humic Substances; D007546:Isoquinolines; D010879:Piperazines; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D013925:Thromboplastin; D014700:Verapamil; D011493:Protein Kinase C; D002118:Calcium